Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine

Eitemau Tebyg

• Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
  gan: Duintjer Tebbens, Radboud J., et al.
  Cyhoeddwyd: (2015)
• Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
  gan: Duintjer Tebbens, Radboud J., et al.
  Cyhoeddwyd: (2018)
• Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
  gan: Duintjer Tebbens, Radboud J., et al.
  Cyhoeddwyd: (2016)
• Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
  gan: Duintjer Tebbens, Radboud J., et al.
  Cyhoeddwyd: (2017)
• Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission
  gan: Thompson, Kimberly M., et al.
  Cyhoeddwyd: (2017)